By Model System

LIDE’s reputation is built on the strength of our comprehensive preclinical platforms, spanning in vitro, in vivo, and ex vivo methodologies. Our capabilities combine established gold-standard approaches with proprietary LIDE technologies, ensuring every study delivers robust, clinically relevant data with efficiency in both time and cost.

We work closely with each client to design studies that align precisely with program goals, selecting the right models and methods to generate meaningful insights.

With over a decade dedicated exclusively to preclinical oncology, and a team of experienced PhD scientists, technicians, and bioinformaticians, LIDE supports your research from concept and study design through full execution. Every service can be performed as a stand-alone study or integrated into an end-to-end, IND-enabling program.